Partek acquired by Illumina
Deal Synopsis
Partek was acquired by Illumina for an undisclosed amount in December, 2023. Press Release.
Seller Details
Founded in 1993, Partek is a leading provider of bioinformatics solutions, specializing in the analysis and interpretation of complex genomic and biomedical data. Their innovative software tools combine advanced statistical algorithms and user-friendly interfaces to empower researchers and clinicians in uncovering valuable insights from large-scale datasets. With a focus on driving impactful discoveries, Partek collaborates closely with the scientific community and industry partners to remain at the forefront of technological advancements in life sciences research and precision medicine.
Buyer Details
Illumina (Nasdaq: ILMN) is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets.